Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATN-224 + Exemestane in Advanced Breast Cancer
NCT00674557Phase 2Terminated
- Sponsor
- Cancer Research UK
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tetrathiomolybdate in breast cancer, sponsored by Cancer Research UK. Started Jun 2008; status: terminated.
02
Drugs
tetrathiomolybdate
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00674557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00674557.